WVP-29645-82233
2 vaccinations
1 coded response
1 check-in
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 240 / VA
- Registered
- 2022-09-29
- Relationship
- Child or adolescent in my care
- Guardian
- BE9-43367-58091
- Race
- Other
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-06
Dose 1 — Pfizer-BioNTech
-
2021-12-01
Dose 2 — Pfizer-BioNTech
-
2022-09-29
Registered in v-safe
-
2022-12-01
Survey response — 12 months, dose 2, dependentMedDRA: Cough, Pyrexia, Respiratory tract congestion — Feeling: GoodFree text: Fever, congestion, lingering coughMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-06 | Pfizer-BioNTech | No |
| 2 | 2021-12-01 | Pfizer-BioNTech | No |
Free text
Release 12 — 12 months, dose 2, dependent
Symptoms: Fever, congestion, lingering cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release